Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Diagnostic Microbiology and Infectious Disease|July 11, 2006
Evaluation of 4 swab transport systems for the recovery of ATCC and clinical strains with characterized resistance mechanismsMaría-Isabel Morosini, Elena Loza, Olga Gutiérrez, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2003
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycinMaría-Isabel Morosini, Rafael Cantón, Elena Loza, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerasesMaría-Isabel Morosini, Elena Loza, Rosa del Campo, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre studyRafael Cantón, David M Livermore, María Isabel Morosini, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa BiofilmsMaría Díez-Aguilar, María Isabel Morosini, Emin Köksal, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention ConcentrationsMaría Díez-Aguilar, María Isabel Morosini, Ana P Tedim, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 5, 2011
MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patientsAna Fernández-Olmos, María García-Castillo, María-Isabel Morosini, et al.
Diagnostic Microbiology and Infectious Disease|November 13, 2007
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic cloneJavier Cobo, María-Isabel Morosini, Vicente Pintado, et al.
Diagnostic Microbiology and Infectious Disease|December 6, 2016
CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimensSergio García-Fernández, Marta Hernández-García, Aránzazu Valverde, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2005
Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in SpainFabio Cafini, Rosa del Campo, Luis Alou, et al.
Pageof 8